Abstract
This manuscript is a formal response to the commentary by A/Prof. Dr. Chen-xi Li and colleagues regarding our previous publication in Advanced Science. We clarify the rationale, methods, and outcomes of our original study and highlight ongoing work in the field of bacterial cancer immunotherapy.